About Aromazin Pharmaceutical
Aromazin Pharmaceutical is a third-generation irreversible aromatase inhibitor containing exemestane, designed for comprehensive laboratory research into estrogen biosynthesis and hormonal pathway modulation. This advanced research compound binds covalently to the aromatase enzyme complex, providing researchers with a powerful tool to investigate estrogen-dependent cellular mechanisms in controlled laboratory environments. Unlike reversible inhibitors, exemestane forms permanent bonds with the enzyme active site, making it particularly valuable for studies requiring sustained aromatase suppression. Research teams at Stroid UK Shop utilise this compound to examine the intricate relationships between estrogen production and various physiological processes in cellular and tissue models.
Research Applications
Scientists investigate Aromazin Pharmaceutical in studies focusing on hormone-dependent cancer cell lines, particularly those expressing estrogen receptors. The compound’s irreversible binding mechanism allows researchers to examine long-term effects of estrogen deprivation on cellular proliferation, apoptosis pathways, and gene expression profiles. Metabolic research teams study exemestane’s effects on lipid metabolism, bone mineralisation processes, and cardiovascular tissue responses in experimental models. Researchers exploring aromatase inhibitors frequently compare exemestane’s irreversible mechanism to reversible inhibitors for comprehensive pathway analysis. Additionally, the compound serves as a valuable reference standard in pharmacokinetic studies and enzyme inhibition assays. Research groups studying endocrine disruption examine how exemestane affects feedback loops in hypothalamic-pituitary-gonadal axis models, providing insights into hormonal regulation mechanisms. Studies investigating post-menopausal hormone profiles utilise exemestane to model estrogen-deficient states, while reproductive biology researchers examine its effects on folliculogenesis and ovarian function in laboratory settings. The compound’s established pharmacological profile makes it essential for validating new selective modulators and comparing their mechanisms to established aromatase inhibition pathways. Researchers studying bone metabolism investigate exemestane’s effects on osteoblast and osteoclast activity in cell culture systems.
Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Exemestane |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.40 g/mol |
| Classification | Irreversible aromatase inhibitor |
| Storage Conditions | Room temperature, dry environment |
| Stability | Verify with supplier |
| Research Grade | Laboratory standard |
Advanced researchers studying hormonal pathways often combine exemestane investigations with peptide modulators to examine complex endocrine interactions and develop comprehensive understanding of estrogen-dependent signalling cascades in experimental models.
Research Compliance
Aromazin Pharmaceutical exemestane is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any clinical applications. Research institutions must ensure proper laboratory protocols, safety procedures, and regulatory compliance when handling this compound. All studies should be conducted by qualified personnel in appropriate laboratory settings with proper documentation and safety measures.
